Navigation Links
CWRU School of Medicine researchers discover new molecule linked to late-stage breast cancer
Date:12/17/2012

CLEVELAND -- Researchers at Case Western Reserve University School of Medicine have identified a molecule linked to more aggressive forms of breast cancer a discovery that could point the way to potential cures.

Until this study, the ribonucleic acid (RNA) molecule called miR-181a had never before been tied to breast cancer metastasis. But when scientists found elevated levels of the molecule in late-stage breast cancer tissues, they in turn tested an inhibitor in mouse models. The approach not only prevented metastasis, but also extended the animals' lives.

"Overall, these findings reinforce our belief that the discovery of miR-181 will become a strong predictive biomarker for breast cancer metastasis, and that the high expression of miR-181 in tumor tissues will pave the way for the development of targeted therapies, better prognosis and increased patient survival," said lead researcher William Schiemann, PhD, associate professor of General Medical Sciences (oncology) at the medical school and a member of the Case Comprehensive Cancer Center.

The study appears online today in The Journal of Clinical Investigation (JCI) and will be published in the journal's January 2013 edition. Its authors include scientists at Case Western Reserve's School of Medicine, the Cleveland Clinic and University Hospitals.

"This work, published in the most important journal for patient-based discoveries, points us in the direction of a new genetic change in women with high-risk breast cancer," said Stanton Gerson, MD, director of the Case Comprehensive Cancer Center. "This research will impact the field by focusing us on new targets for treating and preventing metastasis in patients with breast cancer."

As breast-cancer tumors spread, they become less responsive to chemotherapy. Generating a cell-based system to replicate such changes enabled the research team to establish the molecule's effect on breast cancer metastasis. The team also linked high levels of miR-181 with decreased levels of a protein molecule called Bim, which kills cancer cells during chemotherapy. The combination of low Bim levels and elevated miR-181a levels allowed the breast cancers to -metastasize and resist chemotherapy.

"The identification of an RNA that regulates cell death may offer a natural molecule that can resensitize metastatic breast cancers to chemotherapy," Schiemann said.


'/>"/>
Contact: Christine A. Somosi
christine.somosi@case.edu
216-368-6287
Case Western Reserve University
Source:Eurekalert

Related medicine news :

1. Even Preschoolers View the Overweight Negatively
2. Catastrophic Head Injuries to High School Football Players Rising
3. That impulsive, moody preschooler may grow up to be a problem gambler
4. Some Schools Dont Let Kids Carry Asthma Inhalers
5. Awards to 5 IU School of Medicine physicians address critical need for geriatricians
6. Excessive sleepiness may be cause of learning, attention and school problems
7. Study: More Pre-Teens Get Vaccines When Middle Schools Require Them
8. A place to play: Researcher designs schoolyard for children with autism
9. Fees Lead Some Kids to Skip After-School Sports: Survey
10. Outstanding high school students receive awards to stimulate research interest in digestive diseases
11. The Tennessee Car Accident Lawyers at Michael D. Ponce & Associates Alert Public of CDC Survey Revealing Majority of High School Seniors Admitting to Texting Behind Wheel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2017)... ... September 22, 2017 , ... Happy Living’s mission - to improve the ... it into the entertaining and delicious worlds of theatre and wines. , After ... convinced him to turn his play into a book. The Greener The Grass ( ...
(Date:9/22/2017)... ... September 22, 2017 , ... “Cursed with a Curse: The ... and the freedom experienced when breaking free from this misconception. “Cursed with a ... Harrison. , Published by Christian Faith Publishing, Lysa M. Harrison’s new book is ...
(Date:9/22/2017)... ... September 22, 2017 , ... First ... is celebrating the one year anniversary of its Houston-Fallbrook facility. , “We ... Otinwa, Facility Medical Director of First Choice Emergency Room Houston-Fallbrook. “It has been ...
(Date:9/22/2017)... ... September 22, 2017 , ... Silicon Valley startup Enke ... the go. Their electric toothbrushes aggressively attack oral bacteria by reducing dental plaque ... Combining leading edge Enke technology with a premium timeless design, they want to ...
(Date:9/22/2017)... ... 22, 2017 , ... “Letters From Home”: a moving compilation of letters ... to God. “Letters From Home” is the creation of published author, John Allred, a ... of Jerry Savelle Ministries International, who has traveled and ministered on four continents. , ...
Breaking Medicine News(10 mins):
(Date:9/9/2017)... , Sept. 8, 2017 Dealmed Medical Supplies, ... supplier of medical equipment, supplies, drugs, vaccines, and specialty ... entered into an agreement to acquire Vantage Medical Supplies, ... in Holtsville, New York . ... supplying new and emerging medical practices, will operate under ...
(Date:9/7/2017)...  For nearly two decades, New Life Agency has been committed to ... Today, New Life Agency announces a powerful three-way partnership designed to deliver ... ... ... http://pharmacarecard.com/ (PRNewsfoto/PharmaCareCard) ...
(Date:9/7/2017)... , Sept. 7, 2017  Zimmer Biomet Holdings, ... musculoskeletal healthcare, today announced that it will be participating ... Healthcare Conference at the Grand Hyatt hotel in New ... 2017 at 11:40 a.m. Eastern Time. A ... Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com . ...
Breaking Medicine Technology: